Back to search
Steinert Myotonic Dystrophy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Steinert Myotonic Dystrophy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Steinert Myotonic Dystrophy trials you may qualify forThe purpose of the study is to assess the efficacy, safety, and tolerability of zeleciment basivarsen (DYNE-101) for the treatment of myotonic dystrophy 1 (DM1)…
This is a Phase 1/Phase 2 open-label single arm, multicenter, and multinational study with SAR446268 for treatment of male and female participants 10 to 55 year…
The purpose of this study is to learn about the effects of an investigational medicine, PGN-EDODM1, to see how safe and tolerable multiple administrations of PG…
Cell-free fetal DNA (cffDNA) is present in the maternal blood from the early first trimester of gestation and makes up 5%-20% of the total circulating cell-free…
An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis…
The goal of this observational study, conducted in participants' homes and requiring no travel to a study site, is to better understand disease variability in p…
A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous Delpacibart Etedesiran (abbreviated del-de…
This cross-sectional observational study aims to determine the frequency of falls in patients with myotonic dystrophy type 1 and to identify factors affecting d…
This is a prospective multicentric Italian study to evaluate the arrhythmic risk in myotonic dystrophy type 1.